Master Pharm with estimated PLN 3.71 mln net profit in H1 2018 

The estimated net result of the Master Pharm Group amounted to PLN 3.71 million in the first half of 2018 compared to PLN 1.75 million profit a year earlier, the company has announced.

The consolidated estimated operating result of the group in the first half of 2018 amounted to PLN 5.05 million against PLN 2.44 million profit a year earlier.

The Master Pharm capital group operates in the field of production and marketing of dietary supplements and other food products with health supporting properties, cosmetics, medical devices and food preparations. The company debuted on the Warsaw Stock Exchange in 2016.


Pin It